Annals of oncology : official journal of the European Society for Medical Oncology
-
Randomized Controlled Trial
A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB).
Hot flashes represent a significant problem in men undergoing androgen deprivation therapy. ⋯ These results support that gabapentin decreases hot flashes, to a moderate degree, in men with androgen ablation-related vasomotor dysfunction.